GOVX @ .07: Partnering up @ JP Morgan Conference? GeoVax is due some serius fed $$ for both its AIDS & Zika humna vaccine trials. The time appears right to make a serious deal for big name partners for their important vaccine science and human trial work. LINK: http://www.geovax.com/component/easyblog/entry/2016/12/07/geovax-to-conduct-investor-and-partnering-meetings-during-35th-annual-j-p-morgan-healthcare-conference.html?Itemid=101 NOTE: Here is the link for the human vaccine trials. The start date was June 2016 but was moved back to December, 2016. A major milestone payment is due as these actual human vaccination program gets underway. GOVX is due $7.6M in milestone payments. The GOVX market cap is $3.2M http://www.avac.org/trial/hvtn-114